Company Overview
- Website
- renovion.com
- Phone
- (919) 321-1555
- Employees
- 6
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Recent News & Media
Bronchiectasis Market Size to Reach USD 766.7 Million by 2035, Impelled by Advancements in Diagnostic Improvements and the Escalating Incidence of Bronchiectasis.
- Jan 27, 2025
- biospace.com
Chapel Hill drugmaker sees positive results for lung disease treatment
- May 1, 2024
- bizjournals.com
Bronchiolitis Obliterans Syndrome Market to Grow
- Feb 29, 2024
- globenewswire.com
Renovion concludes Phase II CLIMB study enrolment for bronchiectasis
- Jan 12, 2024
- clinicaltrialsarena.com
Renovion enrols first patient in ARINA-1 lung transplant trial
- Apr 19, 2023
- clinicaltrialsarena.com
Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in Lung Transplant Patients
- Mar 30, 2023
- businesswire.com
Company Leadership
Companies Similar to Renovion
Analyze industry trends and opportunities by examining competitors and companies comparable to Renovion, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |